Cassiopea SPA vs Newron Pharmaceuticals
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Cassiopea SPA is the larger company by market value: $380 M against $190 M for Newron Pharmaceuticals, 2.0 times as much (market caps of Jan 7, 2022 for Cassiopea SPA and Jan 5, 2024 for Newron Pharmaceuticals). Cassiopea SPA's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet. Newron Pharmaceuticals's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Cassiopea SPA SKIN.SW | Newron Pharmaceuticals NP5.F |
|---|---|---|
| Profile | ||
| Country | 🇮🇹 Italy | 🇮🇹 Italy |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Revenue | $0 M | — |
| Net income | $-14 M | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2022 | Market cap Jan 2024 |
Questions and answers#
Which is bigger, Cassiopea SPA or Newron Pharmaceuticals?
Cassiopea SPA is the larger company by market value: $380 M against $190 M for Newron Pharmaceuticals, 2.0 times as much (market caps of Jan 7, 2022 for Cassiopea SPA and Jan 5, 2024 for Newron Pharmaceuticals). Cassiopea SPA's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet. Newron Pharmaceuticals's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.